Skip to main content
. 2015 Nov 5;5(1):259–267. doi: 10.1039/c5tx00171d

Table 3. ROC analysis of the 5 nephrotoxicity biomarkers at the screening stage.

Biomarkers AUC a Sensitivity (%) Specificity (%) Standard error b 95% CI
Lower Upper
Thymidine 0.901 0.956 0.714 0.044 0.815 0.988
LysoPC(16:1) 0.817 0.813 0.786 0.069 0.682 0.952
LysoPC(18:4) 0.806 0.846 0.714 0.064 0.680 0.933
LysoPC(20:5) 0.886 0.791 0.857 0.033 0.821 0.951
LysoPC(22:5) 0.830 0.758 0.786 0.062 0.710 0.951

aThe area under the curve.

bUnder the nonparametric assumption.